Chandra Bhagat Pharma Approves 66 Lakh Warrants at ₹44

Chandra Bhagat Pharma Ltd announced the Board's approval for the allotment of 66,00,000 convertible warrants on a preferential basis at an issue price of ₹44 per warrant. These warrants are convertible into an equal number of equity shares of face value ₹10 each. The total consideration received for this allotment is ₹7,26,00,000 (₹7.26 Crore). The conversion can be exercised within 18 months from the allotment date. The allotment includes both promoters and non-promoters, with specific allocations detailed for nine individuals, including members of the promoter group.